| Patents for A61P 37 - Drugs for immunological or allergic disorders (117,141) |
|---|
| 07/19/2011 | US7981631 Identification of Actinobacillus actinomycetemcomitans antigens for use in the diagnosis, treatment and monitoring of periodontal diseases |
| 07/19/2011 | US7981601 Method of preparing polyepitope chimeric gene vaccine |
| 07/19/2011 | US7981434 Surface exposed immunoglobulin D-binding protein from Moraxella catarrhalis |
| 07/19/2011 | US7981427 has a low level of homology to the enteric canine coronavirus, but which has a high level of homology to all bovine coronavirus strains (eg Quebec and LY138) and human coronavirus strain OC43 |
| 07/19/2011 | US7981420 Therapeutic use of antibodies directed against repulsive guidance molecule (RGM) |
| 07/19/2011 | US7981413 Using cell surface adhesion proteins specific immunoglobulin to target therapeutics to tumorous; immunodiagnostics; immunotherapy |
| 07/19/2011 | CA2485677C Methods of treating allergic reactions |
| 07/19/2011 | CA2472713C N-(benzyl)aminoalkylcarboxylates, phosphinates, phosphonates and tetrazoles as edg receptor agonists |
| 07/19/2011 | CA2459165C Dosage forms having prolonged active ingredient release |
| 07/19/2011 | CA2448561C Aminoquinoline derivatives and their use as adenosine a3 ligands |
| 07/19/2011 | CA2434314C Method to enhance the immunogenicity of an antigen |
| 07/19/2011 | CA2397354C O-methylated rapamycin derivatives for alleviation and inhibition of lymphoproliferative disorders |
| 07/19/2011 | CA2291740C Use of recombinant human uteroglobin in treatment of inflammatory and fibrotic conditions |
| 07/14/2011 | WO2011085231A2 Synthetic virus-like particles conjugated to human papillomavirus capsid peptides for use as vaccines |
| 07/14/2011 | WO2011084967A2 Methods and compositions for providing protective immunity in the elderly |
| 07/14/2011 | WO2011082951A1 Combination preparations comprising a cytokine antagonist and corticosteroid |
| 07/14/2011 | WO2011082950A1 Combination preparations comprising exosomes and corticosteroid |
| 07/14/2011 | WO2011082458A1 Adjuvant immunotherapy for the preventive, curative or palliative treatment of chronic systemic diseases such as cancer, of clinical manifestations associated with these diseases, such as cachexia, and remedying adverse effects of drugs and treatments, such as immunodepression, neutropenia and lymphocytopenia, comprising the association or combination of a specially selected biological response modifier and other antineoplastic compounds and/or other treatments |
| 07/14/2011 | WO2011020933A3 Liposomes covered with the extracellular domain of the apo2l/trail protein |
| 07/14/2011 | WO2010144140A4 Egfr and par2 regulation of intestinal permeability |
| 07/14/2011 | WO2010042644A8 Methods for inducing a sustained immune response againts a b-cell idiotype using autologous anti-idiotypic vaccines |
| 07/14/2011 | US20110172434 Derivatives of heterocycles with 5 members, their preparation and their use as medicaments |
| 07/14/2011 | US20110172310 Di-fluoro containing compounds as cysteine protease inhibitors |
| 07/14/2011 | US20110172285 Proteasome inhibitors |
| 07/14/2011 | US20110172279 N-hydroxyamidinoheterocycles as modulators of indoleamine 2,3-dioxygenase |
| 07/14/2011 | US20110172266 Pyrazolo pyridine derivatives as nadph oxidase inhibitors |
| 07/14/2011 | US20110172263 Indole derivatives as crth2 receptor antagonists |
| 07/14/2011 | US20110172240 Fatty acid fumarate derivatives and their uses |
| 07/14/2011 | US20110172231 2,4- diaminopyrimidine derivatives |
| 07/14/2011 | US20110172216 Pyrazolopyrimidine pi3k inhibitor compounds and methods of use |
| 07/14/2011 | US20110172209 3h-imidazo[4,5-b]pyridin-5-ol derivatives useful in the treatment of gpr81 receptor disorders |
| 07/14/2011 | US20110172202 Selective sphingosine 1 phosphate receptor modulators and methods of chiral synthesis |
| 07/14/2011 | US20110172191 Thieno-pyridine derivatives as mek inhibitors |
| 07/14/2011 | US20110172181 Compositions and Methods of Aloe Polysaccharides |
| 07/14/2011 | US20110172168 Ilt-2 (lir1) variants with increased affinity for mhc class i molecules |
| 07/14/2011 | US20110172151 Derivatives of growth hormone and related proteins, and methods of use thereof |
| 07/14/2011 | US20110172114 Compositions and methods for the treatment of immune related diseases |
| 07/14/2011 | US20110171316 Expression and assembly of human group c rotavirus-like particles and uses thereof |
| 07/14/2011 | US20110171315 Oral recombinant helicobacter pylori vaccine and preparing method thereof |
| 07/14/2011 | US20110171314 Non-viral compositions and methods for transfecting gut cells in vivo |
| 07/14/2011 | US20110171308 Ph-sensitive solid pharmaceutical composition for oral preparation and preparation method thereof |
| 07/14/2011 | US20110171275 Gastroretentive drug delivery system, preparation method and use thereof |
| 07/14/2011 | US20110171267 Anti-fungal composition |
| 07/14/2011 | US20110171265 Composition Comprising Parasite Eggs and Methods for Isolation and Storage of Parasite Eggs |
| 07/14/2011 | US20110171262 Parvoviral capsid with incorporated gly-ala repeat region |
| 07/14/2011 | US20110171259 Novel Compositions and Adjuvants |
| 07/14/2011 | US20110171258 Polyvalent, primary hiv-1 glycoprotein dna vaccines and vaccination methods |
| 07/14/2011 | US20110171256 Viral strains derived from the vaccinia virus lister vacv-107 and uses thereof |
| 07/14/2011 | US20110171254 Cytokine-coated cells and methods of modulating an immune response to an antigen |
| 07/14/2011 | US20110171253 Novel astrovirus |
| 07/14/2011 | US20110171252 Streptococcus suis vaccines and diagnostic tests |
| 07/14/2011 | US20110171250 Synthetic Gene Construct Coding for an HIV1 GAG and Use Thereof for Obtaining Anti-HIV-1 Vaccines |
| 07/14/2011 | US20110171249 Chimeric chikungunya virus and uses thereof |
| 07/14/2011 | US20110171248 Synthetic virus-like particles conjugated to human papillomavirus capsid peptides for use as vaccines |
| 07/14/2011 | US20110171245 Recombinant antigen for diagnosis and prevention of murine typhus |
| 07/14/2011 | US20110171244 Recombinant protein carrying human papillomavirus epitopes inserted in an adenylate cyclase protein or fragment thereof therapeutic uses thereof |
| 07/14/2011 | US20110171241 Stabilized Formulations Containing Anti-Interleukin-6 (IL-6) Antibodies |
| 07/14/2011 | US20110171237 Phep, an amino acid permease of staphylococcus aureus |
| 07/14/2011 | US20110171232 Methods of treating autoimmune diseases caused by small intestinal bacterial overgrowth |
| 07/14/2011 | US20110171228 Methods and Compositions Relating to the Regulation of Apoptosis by MUC1 and BH3-Containing Proapoptotic Proteins |
| 07/14/2011 | US20110171224 PsrP IS A PROTECTIVE ANTIGEN AGAINST PNEUMOCOCCAL INFECTION |
| 07/14/2011 | US20110171223 Anti-peptide antibodies that cross react with protective antigen of bacillus anthracis and uses thereof |
| 07/14/2011 | US20110171220 Pd-1 specific antibodies and uses thereof |
| 07/14/2011 | US20110171218 Compositions and methods for increasing serum half-life |
| 07/14/2011 | US20110171215 Pd-1 specific antibodies and uses thereof |
| 07/14/2011 | US20110171211 Heat shock protein gp96 vaccination and methods of using same |
| 07/14/2011 | US20110171210 Humanized monoclonal antibodies and methods of use |
| 07/14/2011 | US20110171209 Potentiation of Autoimmune and Inflammatory Disease Treatments by Immune Regulatory Oligonucleotide (IRO) Antagonists of TLR7 and TLR9 |
| 07/14/2011 | US20110171207 Compositions and methods for treating inflammation and auto-immune diseases |
| 07/14/2011 | US20110171192 Substituted amine derivative and medicinal composition comprising same as the active ingredient |
| 07/14/2011 | US20110171186 Chondrocyte therapeutic delivery system |
| 07/14/2011 | US20110171178 Compositions and methods of using proislet peptides and analogs thereof |
| 07/14/2011 | US20110171173 Ifn-alpha/beta-independent mechanism of antiviral protection through a novel ligand-receptor pair: ifn- ligands engage a novel receptor ifn-rn (crf2-12) and il-10r2 (crf2-4) for signaling andinduction of biological activities |
| 07/14/2011 | US20110171171 Bridged secondary amines and use thereof as iap bir domain binding compounds |
| 07/14/2011 | US20110171170 Cytotoxic t cell defined egfr peptide and an optimized derivative peptide |
| 07/14/2011 | US20110171169 Peptides for active anti-cytokine immunization |
| 07/14/2011 | US20110171168 Human g-csf analogs and methods of making and using thereof |
| 07/14/2011 | US20110171140 Absorption of therapeutic agents across mucosal membranes or the skin |
| 07/14/2011 | US20110171126 Enhanced Cytotoxicity of Anti-CD74 and Anti-HLA-DR Antibodies with Interferon-Gamma |
| 07/14/2011 | CA2836154A1 Chemical reagents for the activation of polysaccharides in the preparation of conjugate vaccines |
| 07/14/2011 | CA2836140A1 Chemical reagents for the activation of polysaccharides in the preparation of conjugate vaccines |
| 07/14/2011 | CA2786306A1 Methods and compositions for providing protective immunity in the elderly |
| 07/14/2011 | CA2785226A1 Photo-inactivated viruses and systems and methods of using the same |
| 07/14/2011 | CA2781576A1 Combination preparation including a corticosteroid and exosomes |
| 07/14/2011 | CA2781223A1 Combination preparation including a cytokine antagonist and corticosteroid |
| 07/13/2011 | EP2343316A1 Ligand binding site of RAGE and uses thereof |
| 07/13/2011 | EP2343308A2 Novel immunogenic compositions for the prevention and treatment of meningococcal disease |
| 07/13/2011 | EP2343306A1 Glycolipid derivatives, process for production of the same, intermediates for synthesis thereof, and process for production of the intermediates |
| 07/13/2011 | EP2343299A1 Heteroaryl substituted pyrrolo[2,3-b]pyridines and pyrrolo[2,3-b]pyrimidines as Janus kinase inhibitors |
| 07/13/2011 | EP2343298A1 Heteroaryl substituted pyrrolo[2,3-b]pyridines and pyrrolo[2,3-b]pyrimidines as Janus kinase inhibitors |
| 07/13/2011 | EP2343081A1 Interferon analogs |
| 07/13/2011 | EP2343077A1 Derivatives of totally N-desulphated glycosaminoglycans as heparanase inhibitors, endowed with antiangiogenic activity and devoid of anticoagulating effect |
| 07/13/2011 | EP2343072A1 Remedy |
| 07/13/2011 | EP2343065A1 The pharmaceutical composition containing ferulic acid and matrine compounds, the preparation and the use thereof |
| 07/13/2011 | EP2342979A2 Composition for improving membrane composition and functioning of cells |
| 07/13/2011 | EP2342978A2 Composition for improving membrane composition and functioning of cells |
| 07/13/2011 | EP2342976A2 Composition for improving membrane composition and functioning of cells |
| 07/13/2011 | EP2342975A2 Composition for improving membrane composition and functioning of cells |
| 07/13/2011 | EP2342974A2 Composition for improving membrane composition and functioning of cells |
| 07/13/2011 | EP2342335A1 Novel gene cluster |